Loading…

POLR2F, ATP6V0A1 and PRNP Expression in Colorectal Cancer: New Molecules with Prognostic Significance?

Background: DNA-directed RNA polymerase II subunit F (POLR2F), a subunit of the V0 domain of the vacuolar ATPase (ATP6V0A1) and the prion protein (PRNP) are molecules of potential importance in carcinogenesis and targeted cancer therapy. However, their expression has not been studied in colorectal c...

Full description

Saved in:
Bibliographic Details
Published in:Anticancer research 2008-03, Vol.28 (2B), p.1221
Main Authors: Antonacopoulou, Anna G, Grivas, Petros D, Skarlas, Lambros, Kalofonos, Melpomeni, Scopa, Chrisoula D, Kalofonos, Haralabos P
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 2B
container_start_page 1221
container_title Anticancer research
container_volume 28
creator Antonacopoulou, Anna G
Grivas, Petros D
Skarlas, Lambros
Kalofonos, Melpomeni
Scopa, Chrisoula D
Kalofonos, Haralabos P
description Background: DNA-directed RNA polymerase II subunit F (POLR2F), a subunit of the V0 domain of the vacuolar ATPase (ATP6V0A1) and the prion protein (PRNP) are molecules of potential importance in carcinogenesis and targeted cancer therapy. However, their expression has not been studied in colorectal carcinomas. Patients and Methods: Expression microarray data were analyzed using a novel computational tool to reveal elevated levels of POLR2F, ATP6V0A1 and PRNP in relapsed colorectal carcinoma patients. The mRNA levels of POLR2F, ATP6V0A1 and PRNP were evaluated by quantitative RT-PCR in 70 colorectal carcinomas and 17 normal tissue specimens and were correlated with clinicopathological parameters. Results: POLR2F and PRNP were up-regulated in colorectal carcinomas. Moreover, a significant difference in the expression levels of all three molecules between the right colon and the rectum was observed. High expression levels of POLR2F and ATP6V0A1 correlated with improved 3-year survival. Moreover, PRNP expression constituted an independent prognostic factor of the 3-year survival in multivariate analysis. Conclusion: POLR2F and PRNP exhibited elevated levels in carcinomas compared to normal tissue samples suggesting a possible role for these molecules in colorectal cancer. The association of the three molecules with survival or disease prognosis warrants further investigation.
format article
fullrecord <record><control><sourceid>pubmed_highw</sourceid><recordid>TN_cdi_pubmed_primary_18505059</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18505059</sourcerecordid><originalsourceid>FETCH-LOGICAL-h240t-7fe8eafb2e519e280669c96f2bb0aa022799e1904cfabbb5d12a98525f53f7833</originalsourceid><addsrcrecordid>eNo1z1FPwjAUBeDGaATRv2D65JNL2lu6tb4YXEBNEBZEX5d2tKymbKQdQf-9EDT34bx8OTn3DPVpJmmScUbOUZ8AJ0lGCO-hqxi_CElTKdgl6lHByeFkH9liPl3A5B6PlkX6SUYUq2aFi8WswOPvbTAxurbBrsF569tgqk55nKumMuEBz8wev7XeVDtvIt67rsZFaNdNGztX4Xe3bpx11RE_XqMLq3w0N385QB-T8TJ_Sabz59d8NE1qGJIuyawRRlkNhlNpQBwHVzK1oDVRigBkUhoqybCySmvNVxSUFBy45cxmgrEBuj31bnd6Y1blNriNCj_l_8MHcHcCtVvXexdMGTfK-wNnpQogSngqKQBlv2B5XmQ</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>POLR2F, ATP6V0A1 and PRNP Expression in Colorectal Cancer: New Molecules with Prognostic Significance?</title><source>EZB Electronic Journals Library</source><creator>Antonacopoulou, Anna G ; Grivas, Petros D ; Skarlas, Lambros ; Kalofonos, Melpomeni ; Scopa, Chrisoula D ; Kalofonos, Haralabos P</creator><creatorcontrib>Antonacopoulou, Anna G ; Grivas, Petros D ; Skarlas, Lambros ; Kalofonos, Melpomeni ; Scopa, Chrisoula D ; Kalofonos, Haralabos P</creatorcontrib><description>Background: DNA-directed RNA polymerase II subunit F (POLR2F), a subunit of the V0 domain of the vacuolar ATPase (ATP6V0A1) and the prion protein (PRNP) are molecules of potential importance in carcinogenesis and targeted cancer therapy. However, their expression has not been studied in colorectal carcinomas. Patients and Methods: Expression microarray data were analyzed using a novel computational tool to reveal elevated levels of POLR2F, ATP6V0A1 and PRNP in relapsed colorectal carcinoma patients. The mRNA levels of POLR2F, ATP6V0A1 and PRNP were evaluated by quantitative RT-PCR in 70 colorectal carcinomas and 17 normal tissue specimens and were correlated with clinicopathological parameters. Results: POLR2F and PRNP were up-regulated in colorectal carcinomas. Moreover, a significant difference in the expression levels of all three molecules between the right colon and the rectum was observed. High expression levels of POLR2F and ATP6V0A1 correlated with improved 3-year survival. Moreover, PRNP expression constituted an independent prognostic factor of the 3-year survival in multivariate analysis. Conclusion: POLR2F and PRNP exhibited elevated levels in carcinomas compared to normal tissue samples suggesting a possible role for these molecules in colorectal cancer. The association of the three molecules with survival or disease prognosis warrants further investigation.</description><identifier>ISSN: 0250-7005</identifier><identifier>EISSN: 1791-7530</identifier><identifier>PMID: 18505059</identifier><language>eng</language><publisher>Greece: International Institute of Anticancer Research</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Colorectal Neoplasms - enzymology ; Colorectal Neoplasms - genetics ; Colorectal Neoplasms - metabolism ; Colorectal Neoplasms - pathology ; DNA-Directed RNA Polymerases - biosynthesis ; DNA-Directed RNA Polymerases - genetics ; Female ; Gene Expression ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Prion Proteins ; Prions - biosynthesis ; Prions - genetics ; Prognosis ; RNA Polymerase II - biosynthesis ; RNA Polymerase II - genetics ; RNA, Messenger - biosynthesis ; RNA, Messenger - genetics ; Vacuolar Proton-Translocating ATPases - biosynthesis ; Vacuolar Proton-Translocating ATPases - genetics</subject><ispartof>Anticancer research, 2008-03, Vol.28 (2B), p.1221</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18505059$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Antonacopoulou, Anna G</creatorcontrib><creatorcontrib>Grivas, Petros D</creatorcontrib><creatorcontrib>Skarlas, Lambros</creatorcontrib><creatorcontrib>Kalofonos, Melpomeni</creatorcontrib><creatorcontrib>Scopa, Chrisoula D</creatorcontrib><creatorcontrib>Kalofonos, Haralabos P</creatorcontrib><title>POLR2F, ATP6V0A1 and PRNP Expression in Colorectal Cancer: New Molecules with Prognostic Significance?</title><title>Anticancer research</title><addtitle>Anticancer Res</addtitle><description>Background: DNA-directed RNA polymerase II subunit F (POLR2F), a subunit of the V0 domain of the vacuolar ATPase (ATP6V0A1) and the prion protein (PRNP) are molecules of potential importance in carcinogenesis and targeted cancer therapy. However, their expression has not been studied in colorectal carcinomas. Patients and Methods: Expression microarray data were analyzed using a novel computational tool to reveal elevated levels of POLR2F, ATP6V0A1 and PRNP in relapsed colorectal carcinoma patients. The mRNA levels of POLR2F, ATP6V0A1 and PRNP were evaluated by quantitative RT-PCR in 70 colorectal carcinomas and 17 normal tissue specimens and were correlated with clinicopathological parameters. Results: POLR2F and PRNP were up-regulated in colorectal carcinomas. Moreover, a significant difference in the expression levels of all three molecules between the right colon and the rectum was observed. High expression levels of POLR2F and ATP6V0A1 correlated with improved 3-year survival. Moreover, PRNP expression constituted an independent prognostic factor of the 3-year survival in multivariate analysis. Conclusion: POLR2F and PRNP exhibited elevated levels in carcinomas compared to normal tissue samples suggesting a possible role for these molecules in colorectal cancer. The association of the three molecules with survival or disease prognosis warrants further investigation.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Colorectal Neoplasms - enzymology</subject><subject>Colorectal Neoplasms - genetics</subject><subject>Colorectal Neoplasms - metabolism</subject><subject>Colorectal Neoplasms - pathology</subject><subject>DNA-Directed RNA Polymerases - biosynthesis</subject><subject>DNA-Directed RNA Polymerases - genetics</subject><subject>Female</subject><subject>Gene Expression</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Prion Proteins</subject><subject>Prions - biosynthesis</subject><subject>Prions - genetics</subject><subject>Prognosis</subject><subject>RNA Polymerase II - biosynthesis</subject><subject>RNA Polymerase II - genetics</subject><subject>RNA, Messenger - biosynthesis</subject><subject>RNA, Messenger - genetics</subject><subject>Vacuolar Proton-Translocating ATPases - biosynthesis</subject><subject>Vacuolar Proton-Translocating ATPases - genetics</subject><issn>0250-7005</issn><issn>1791-7530</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNo1z1FPwjAUBeDGaATRv2D65JNL2lu6tb4YXEBNEBZEX5d2tKymbKQdQf-9EDT34bx8OTn3DPVpJmmScUbOUZ8AJ0lGCO-hqxi_CElTKdgl6lHByeFkH9liPl3A5B6PlkX6SUYUq2aFi8WswOPvbTAxurbBrsF569tgqk55nKumMuEBz8wev7XeVDtvIt67rsZFaNdNGztX4Xe3bpx11RE_XqMLq3w0N385QB-T8TJ_Sabz59d8NE1qGJIuyawRRlkNhlNpQBwHVzK1oDVRigBkUhoqybCySmvNVxSUFBy45cxmgrEBuj31bnd6Y1blNriNCj_l_8MHcHcCtVvXexdMGTfK-wNnpQogSngqKQBlv2B5XmQ</recordid><startdate>20080301</startdate><enddate>20080301</enddate><creator>Antonacopoulou, Anna G</creator><creator>Grivas, Petros D</creator><creator>Skarlas, Lambros</creator><creator>Kalofonos, Melpomeni</creator><creator>Scopa, Chrisoula D</creator><creator>Kalofonos, Haralabos P</creator><general>International Institute of Anticancer Research</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20080301</creationdate><title>POLR2F, ATP6V0A1 and PRNP Expression in Colorectal Cancer: New Molecules with Prognostic Significance?</title><author>Antonacopoulou, Anna G ; Grivas, Petros D ; Skarlas, Lambros ; Kalofonos, Melpomeni ; Scopa, Chrisoula D ; Kalofonos, Haralabos P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h240t-7fe8eafb2e519e280669c96f2bb0aa022799e1904cfabbb5d12a98525f53f7833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Colorectal Neoplasms - enzymology</topic><topic>Colorectal Neoplasms - genetics</topic><topic>Colorectal Neoplasms - metabolism</topic><topic>Colorectal Neoplasms - pathology</topic><topic>DNA-Directed RNA Polymerases - biosynthesis</topic><topic>DNA-Directed RNA Polymerases - genetics</topic><topic>Female</topic><topic>Gene Expression</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Prion Proteins</topic><topic>Prions - biosynthesis</topic><topic>Prions - genetics</topic><topic>Prognosis</topic><topic>RNA Polymerase II - biosynthesis</topic><topic>RNA Polymerase II - genetics</topic><topic>RNA, Messenger - biosynthesis</topic><topic>RNA, Messenger - genetics</topic><topic>Vacuolar Proton-Translocating ATPases - biosynthesis</topic><topic>Vacuolar Proton-Translocating ATPases - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Antonacopoulou, Anna G</creatorcontrib><creatorcontrib>Grivas, Petros D</creatorcontrib><creatorcontrib>Skarlas, Lambros</creatorcontrib><creatorcontrib>Kalofonos, Melpomeni</creatorcontrib><creatorcontrib>Scopa, Chrisoula D</creatorcontrib><creatorcontrib>Kalofonos, Haralabos P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Anticancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Antonacopoulou, Anna G</au><au>Grivas, Petros D</au><au>Skarlas, Lambros</au><au>Kalofonos, Melpomeni</au><au>Scopa, Chrisoula D</au><au>Kalofonos, Haralabos P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>POLR2F, ATP6V0A1 and PRNP Expression in Colorectal Cancer: New Molecules with Prognostic Significance?</atitle><jtitle>Anticancer research</jtitle><addtitle>Anticancer Res</addtitle><date>2008-03-01</date><risdate>2008</risdate><volume>28</volume><issue>2B</issue><spage>1221</spage><pages>1221-</pages><issn>0250-7005</issn><eissn>1791-7530</eissn><abstract>Background: DNA-directed RNA polymerase II subunit F (POLR2F), a subunit of the V0 domain of the vacuolar ATPase (ATP6V0A1) and the prion protein (PRNP) are molecules of potential importance in carcinogenesis and targeted cancer therapy. However, their expression has not been studied in colorectal carcinomas. Patients and Methods: Expression microarray data were analyzed using a novel computational tool to reveal elevated levels of POLR2F, ATP6V0A1 and PRNP in relapsed colorectal carcinoma patients. The mRNA levels of POLR2F, ATP6V0A1 and PRNP were evaluated by quantitative RT-PCR in 70 colorectal carcinomas and 17 normal tissue specimens and were correlated with clinicopathological parameters. Results: POLR2F and PRNP were up-regulated in colorectal carcinomas. Moreover, a significant difference in the expression levels of all three molecules between the right colon and the rectum was observed. High expression levels of POLR2F and ATP6V0A1 correlated with improved 3-year survival. Moreover, PRNP expression constituted an independent prognostic factor of the 3-year survival in multivariate analysis. Conclusion: POLR2F and PRNP exhibited elevated levels in carcinomas compared to normal tissue samples suggesting a possible role for these molecules in colorectal cancer. The association of the three molecules with survival or disease prognosis warrants further investigation.</abstract><cop>Greece</cop><pub>International Institute of Anticancer Research</pub><pmid>18505059</pmid></addata></record>
fulltext fulltext
identifier ISSN: 0250-7005
ispartof Anticancer research, 2008-03, Vol.28 (2B), p.1221
issn 0250-7005
1791-7530
language eng
recordid cdi_pubmed_primary_18505059
source EZB Electronic Journals Library
subjects Adult
Aged
Aged, 80 and over
Colorectal Neoplasms - enzymology
Colorectal Neoplasms - genetics
Colorectal Neoplasms - metabolism
Colorectal Neoplasms - pathology
DNA-Directed RNA Polymerases - biosynthesis
DNA-Directed RNA Polymerases - genetics
Female
Gene Expression
Humans
Male
Middle Aged
Neoplasm Staging
Prion Proteins
Prions - biosynthesis
Prions - genetics
Prognosis
RNA Polymerase II - biosynthesis
RNA Polymerase II - genetics
RNA, Messenger - biosynthesis
RNA, Messenger - genetics
Vacuolar Proton-Translocating ATPases - biosynthesis
Vacuolar Proton-Translocating ATPases - genetics
title POLR2F, ATP6V0A1 and PRNP Expression in Colorectal Cancer: New Molecules with Prognostic Significance?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T13%3A37%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_highw&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=POLR2F,%20ATP6V0A1%20and%20PRNP%20Expression%20in%20Colorectal%20Cancer:%20New%20Molecules%20with%20Prognostic%20Significance?&rft.jtitle=Anticancer%20research&rft.au=Antonacopoulou,%20Anna%20G&rft.date=2008-03-01&rft.volume=28&rft.issue=2B&rft.spage=1221&rft.pages=1221-&rft.issn=0250-7005&rft.eissn=1791-7530&rft_id=info:doi/&rft_dat=%3Cpubmed_highw%3E18505059%3C/pubmed_highw%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-h240t-7fe8eafb2e519e280669c96f2bb0aa022799e1904cfabbb5d12a98525f53f7833%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/18505059&rfr_iscdi=true